calendar
353 catalysts · 4,876 phase readout · 2,342 8k filing · 286 earnings · 274 pdufa · 129 phase 2 completion · 61 phase 1 completion
next 91 dayslessmore
MonWedFri
353 catalysts · 4,876 phase readout · 2,342 8k filing · 286 earnings · 274 pdufa · 129 phase 2 completion · 61 phase 1 completion
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Therapy area: Gastrointestinal, Oncology. Indication: Bile Duct Cancer (Cholangiocarcinoma), Hepatocellular Carcinoma, Liver Cancer, Liver Cirrhosis, Metastatic Liver Cancer
Therapy area: Central Nervous System. Indication: Unspecified Pain
Therapy area: Cardiovascular. Indication: Hypertension
Therapy area: Infectious Disease. Indication: Hepatitis B
Therapy area: Undisclosed. Indication: Unspecified
Therapy area: Oncology. Indication: Non-Small Cell Lung Cancer, Solid Tumor
Therapy area: Central Nervous System, Dermatology, Ear Nose Throat Disorders, Gastrointestinal, Genito Urinary System, Infectious Disease, Mouth and Dental Disorders, Respiratory. Indication: Abscess, Acne Vulgaris, Acute Bacterial Sinusitis, Acute Bronchitis, Acute Pharyngitis, Bacterial Pneumonia, Bacterial Respiratory Tract Infections, Bartonella Infections, Bronchitis, Carbuncle, Cellulitis, Chlamydia trachomatis Pneumonia, Chronic Bronchitis, Community Acquired Pneumonia, Community-Acquired
Therapy area: Cardiovascular, Metabolic Disorders. Indication: Congestive Heart Failure (Heart Failure), Type 2 Diabetes
Anticipated earnings call for NOVARTIS AG ($NVS).
Anticipated earnings call for INCYTE CORP ($INCY).
Anticipated earnings call for ECOLAB INC. ($ECL).
Anticipated earnings call for Orion Group Holdings Inc ($ORN).
Therapy area: Oncology. Indication: Cervical Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Esophageal Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Gastric Cancer, Head And Neck Cancer, Head And Neck Squamous Cell Carcinoma (HNSC), Hepatocellular Carcinoma, Hypopharyngeal Cancer, Laryngeal Cancer, Malignant Pleural Mesothelioma, Melanoma, Non-Small Cell Lung Carcinoma, Oral Cancer, Oral Cavity (Mouth) Cancer, Oropharyngeal Cancer, Ovarian Cancer, Pancreatic Cancer, Re
Therapy area: Cardiovascular. Indication: Cerebrovascular Disease, Ischemia
Therapy area: Hematological Disorders. Indication: Hemophilia A (Factor VIII Deficiency)
Anticipated earnings call for AbbVie Inc. ($ABBV).
Anticipated earnings call for ASTRAZENECA PLC ($AZN).
Anticipated earnings call for GSK plc ($GSK).
Anticipated earnings call for REGENERON PHARMACEUTICALS, INC. ($REGN).
Anticipated earnings call for TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA).
Anticipated earnings call for GLAUKOS Corp ($GKOS).
Anticipated earnings call for BIOGEN INC. ($BIIB).
Anticipated earnings call for Bausch & Lomb Corp ($BLCO).
Anticipated earnings call for SBA COMMUNICATIONS CORP ($SBAC).
Anticipated earnings call for AGIOS PHARMACEUTICALS, INC. ($AGIO).
Anticipated earnings call for IONIS PHARMACEUTICALS INC ($IONS).
Anticipated earnings call for Avantor, Inc. ($AVTR).
Therapy area: Infectious Disease. Indication: Aspergillosis, Candidiasis, Cryptococcal Meningitis, Cryptococcosis, Zygomycosis (Mucormycosis)
Therapy area: Immunology, Musculoskeletal Disorders. Indication: Osteoporosis, Rheumatoid Arthritis, Sarcopenia
Therapy area: Central Nervous System. Indication: Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome)
Therapy area: Hematological Disorders. Indication: Hemorrhage
Therapy area: Gastrointestinal. Indication: Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Therapy area: Oncology. Indication: B-Cell Non-Hodgkin Lymphoma, Follicular Lymphoma
Therapy area: Oncology. Indication: Acute Lymphoblastic Lymphoma, Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia), B-Cell Leukemia, Chronic Lymphocytic Leukemia (CLL), Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia), Lymphoma, Non-Hodgkin Lymphoma, Unspecified B-Cell Lymphomas
Therapy area: Central Nervous System. Indication: Post-Operative Pain
Therapy area: Infectious Disease. Indication: Helicobacter pylori Infections
Therapy area: Metabolic Disorders. Indication: Type 1 Diabetes (Juvenile Diabetes)
Therapy area: Musculoskeletal Disorders. Indication: Myotonic Dystrophy
Therapy area: Oncology. Indication: Solid Tumor
Therapy area: Cardiovascular, Genetic Disorders. Indication: Edema, Polycystic Kidney Disease
Therapy area: Immunology. Indication: Rheumatoid Arthritis
Therapy area: Ophthalmology. Indication: Age Related Macular Degeneration, Dry (Atrophic) Macular Degeneration, Geographic Atrophy
Therapy area: Central Nervous System, Ear Nose Throat Disorders, Hormonal Disorders, Immunology, Musculoskeletal Disorders, Other Diseases, Women's Health. Indication: Ankylosing Spondylitis (Bekhterev's Disease), Dental Pain (Toothache/Tooth Pain), Fever, Fibromyalgia (Fibromyalgia Syndrome), Gouty Arthritis (Gout), Hyperthyroidism, Laryngitis, Low Back Pain, Mixed Pain (Nociceptive Pain/Neuropathic Pain), Musculoskeletal Inflammation, Musculoskeletal Pain, Myalgia (Muscle Pain), Neuropathic Pa
Therapy area: Oncology. Indication: Small-Cell Lung Cancer
Therapy area: Respiratory. Indication: Streptococcal Pneumonia